Navigation Links
InVitria's Cellastim Showcased in Nature Article

FORT COLLINS, Colo., Oct. 7 /PRNewswire/ -- A study published in the scientific journal Nature examining embryonic stem cell self-renewal, reported that InVitria's ( Cellastim (recombinant human serum albumin) was an effective replacement to bovine serum albumin in ES-cell culture.

The article entitled, "The ground state of embryonic stem cell self-renewal," disclosed that researchers used Cellastim as a recombinant albumin in place of animal-derived serum to eliminate contaminants in the cell culture. The Cellastim was a contributing factor in the enhancement of bulk passaging and clonal propagation (1).

"This study further supports the use of InVitria's Cellastim as an enhancement to cell culture media," said InVitria President Scott Deeter. "Cellastim is the only supplement available that not only improves cell culture performance, but does so while maintaining a defined and animal free media."

About InVitria (

InVitria has developed cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, regenerative medicine, life science research and diagnostics industry. Cellastim is used to enhance cell growth and productivity. It is animal component free and has been used as a cell culture ingredient in regenerative medicine, mammalian cell culture media, stem cell media and primary cell media. (See

For more information about the InVitria line of products, please e-mail or call 1-800-916-8311.

(1) Ying, al. The ground state of embryonic stem cell self- renewal. Nature 453, 519-524 (May 2008).

Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Brain Signature for Cigarette Cravings Identified
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
7. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
8. Tumor Eradication Article Published by Cancer Research
9. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
10. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
11. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Post Your Comments:
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Trovagene, ... molecular diagnostics, today announced that Chief Executive Officer Antonius ... at the 27 th Annual Piper Jaffray Healthcare ... Conference at the New York Palace Hotel in ... 2015 at 1:30 p.m. EST. Mr. Schuh will be ...
(Date:11/25/2015)... 2015 Endo International plc (NASDAQ: ENDP ) ... President and CEO, will discuss corporate updates at the 27 ... New York on Wednesday, December 2, 2015 at ... Investor Relations, and then the link to the event. Participants ... time to visit the site and download any streaming media ...
Breaking Medicine Technology:
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When ... that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In ... She developed the patent-pending RECOVERY BRA for added comfort and support. The bra ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted ... as raising public awareness of the disorder while helping to bring expert medical ... $35,000 to bolster progress at the Tuberous Sclerosis Complex Center at Ann & ...
Breaking Medicine News(10 mins):